CAREDX, INC. Proceeds from Debt, Net of Issuance Costs
CAREDX, INC. (CDNA) reported Proceeds from Debt, Net of Issuance Costs of $0 for the 12-month period ending 2020-12-31, per its 10-K filed 2021-02-24.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromDebtNetOfIssuanceCosts · last filed 2021-02-24
- CAREDX, INC. proceeds from debt, net of issuance costs for the quarter ending 2019-12-31 was $0.00.
- CAREDX, INC. proceeds from debt, net of issuance costs for the quarter ending 2019-09-30 was $0.00.
- CAREDX, INC. proceeds from debt, net of issuance costs for the quarter ending 2018-12-31 was $0.00.
- CAREDX, INC. proceeds from debt, net of issuance costs for the quarter ending 2018-09-30 was $0.00.
- CAREDX, INC. proceeds from debt, net of issuance costs for fiscal 2020 was $0.00.
- CAREDX, INC. proceeds from debt, net of issuance costs for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
- CAREDX, INC. proceeds from debt, net of issuance costs for fiscal 2018 was $14.28M, a 40.50% decline from fiscal 2017.
- CAREDX, INC. proceeds from debt, net of issuance costs for fiscal 2017 was $24.00M.
| Period end | Proceeds from Debt, Net of Issuance Costs 3 month | Proceeds from Debt, Net of Issuance Costs 6 month | Proceeds from Debt, Net of Issuance Costs 9 month | Proceeds from Debt, Net of Issuance Costs 12 month |
|---|---|---|---|---|
| 2020-12-31 | $0.00 10-K · filed 2021-02-24 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $0.00 derived: sum of 2 quarters · filed 2021-02-24 | $0.00 10-K · filed 2021-02-24 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $0.00 10-Q · filed 2019-10-31 | ||
| 2019-06-30 | $0.00 10-Q · filed 2019-08-01 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $0.00 derived: sum of 2 quarters · filed 2021-02-24 | $14.28M derived: sum of 3 quarters · filed 2021-02-24 | $14.28M 10-K · filed 2021-02-24 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $14.28M derived: sum of 2 quarters · filed 2019-10-31 | $14.28M 10-Q · filed 2019-10-31 | $14.28M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-06-30 | $14.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $14.28M 10-Q · filed 2019-08-01 | $14.28M derived: sum of 3 quarters · filed 2020-02-28 | $14.28M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-03-31 | $0.00 10-Q · filed 2018-05-10 | $0.00 derived: sum of 2 quarters · filed 2020-02-28 | $0.00 derived: sum of 3 quarters · filed 2020-02-28 | $0.00 derived: sum of 4 quarters · filed 2020-02-28 |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $0.00 derived: sum of 2 quarters · filed 2020-02-28 | $0.00 derived: sum of 3 quarters · filed 2020-02-28 | $24.00M 10-K · filed 2020-02-28 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $0.00 derived: sum of 2 quarters · filed 2018-11-08 | $24.00M 10-Q · filed 2018-11-08 | $24.00M derived: sum of 4 quarters · filed 2019-03-06 |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $24.00M 10-Q · filed 2018-08-09 | $24.00M derived: sum of 3 quarters · filed 2019-03-06 | $24.00M derived: sum of 4 quarters · filed 2019-03-06 |
| 2017-03-31 | $24.00M 10-Q · filed 2018-05-10 | $24.00M derived: sum of 2 quarters · filed 2019-03-06 | $24.00M derived: sum of 3 quarters · filed 2019-03-06 | |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | $0.00 derived: sum of 2 quarters · filed 2019-03-06 | $0.00 10-K · filed 2019-03-06 | |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $0.00 10-Q · filed 2017-11-09 | ||
| 2016-06-30 | $0.00 10-Q · filed 2016-08-22 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-22 | $0.00 derived: sum of 2 quarters · filed 2018-03-22 | $0.00 derived: sum of 3 quarters · filed 2018-03-22 | $15.63M 10-K · filed 2018-03-22 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $0.00 derived: sum of 2 quarters · filed 2016-11-14 | $15.63M 10-Q · filed 2016-11-14 | $10.64M derived: sum of 4 quarters · filed 2017-04-21 |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-22 | $15.63M 10-Q · filed 2016-08-22 | $10.64M derived: sum of 3 quarters · filed 2017-04-21 | $10.64M derived: sum of 4 quarters · filed 2017-04-21 |
| 2015-03-31 | $15.63M 10-Q · filed 2016-05-16 | $10.64M derived: sum of 2 quarters · filed 2017-04-21 | $10.64M derived: sum of 3 quarters · filed 2017-04-21 | $15.63M derived: sum of 4 quarters · filed 2017-04-21 |
| 2014-12-31 | -$4.98M derived: 10-K 12 month − 10-Q 9 month · filed 2017-04-21 | -$4.98M derived: sum of 2 quarters · filed 2017-04-21 | $0.00 derived: sum of 3 quarters · filed 2017-04-21 | $0.00 10-K · filed 2017-04-21 |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13 | $4.98M derived: sum of 2 quarters · filed 2015-11-13 | $4.98M 10-Q · filed 2015-11-13 | $4.98M derived: sum of 4 quarters · filed 2016-03-29 |
| 2014-06-30 | $4.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-28 | $4.98M 10-Q · filed 2015-08-12 | $4.98M derived: sum of 3 quarters · filed 2016-03-29 | $4.98M derived: sum of 4 quarters · filed 2016-03-29 |
| 2014-03-31 | $0.00 10-Q · filed 2015-05-14 | $0.00 derived: sum of 2 quarters · filed 2016-03-29 | $0.00 derived: sum of 3 quarters · filed 2016-03-29 | |
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-29 | $0.00 derived: sum of 2 quarters · filed 2016-03-29 | $0.00 10-K · filed 2016-03-29 | |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | $0.00 10-Q · filed 2014-11-14 | ||
| 2013-06-30 | $0.00 10-Q · filed 2014-08-28 | |||
| 2012-12-31 | $14.65M 10-K · filed 2015-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |